Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Diagnostic Atlas of Gastroesophageal Reflux Disease: A New Histology-based Method
    Unavailable
    Diagnostic Atlas of Gastroesophageal Reflux Disease: A New Histology-based Method
    Unavailable
    Diagnostic Atlas of Gastroesophageal Reflux Disease: A New Histology-based Method
    Ebook267 pages7 hours

    Diagnostic Atlas of Gastroesophageal Reflux Disease: A New Histology-based Method

    By Parakrama T. Chandrasoma

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Gastroesophageal reflux is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market. The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac) and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux.

    Unfortunately, this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare, reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world.

    At present, there is no histologic test that has any practical value in the diagnosis of reflux disease. The only histologic diagnostic criteria are related to changes in the squamous epithelium which are too insensitive and nonspecific for effective patient management. It is widely recognized that columnar metaplasia of the esophagus (manifest histologically as cardiac, oxyntocardiac and intestinal epithelia) is caused by reflux. However, except for intestinal metaplasia, which is diagnostic for Barrett esophagus, these columnar epithelia are not used to diagnose reflux disease in biopsies. The reason for this is that these epithelial types are indistinguishable from "normal" "gastric" cardiac mucosa. In standard histology texts, this "normal gastric cardia" is 2-3 cm long.

    In the mid-1990s, Dr. Chandrasoma and his team at USC produced autopsy data suggesting that cardiac and oxyntocardiac mucosa is normally absent from this region and that their presence in biopsies was histologic evidence of reflux disease. From this data, they determined that the presence of cardiac mucosa was a pathologic entity caused by reflux and could therefore be used as a highly specific and sensitive diagnostic criterion for the histologic diagnosis of reflux disease. They call this entity "reflux carditis". In addition, the length of these metaplastic columnar epithelia in the esophagus was an accurate measure of the severity of reflux disease in a given patient.

    At present, there is some controversy over whether cardiac mucosa is totally absent or present normally to the extent of 0-4 mm. While this should not be a deterrent to changing criteria which are dependent on there normally being 20-30 cm of cardiac mucosa, there has been little mainstream attempt to change existing endoscopic and pathologic diagnostic criteria in the mainstream of either gastroenterology or pathology.

    The ATLAS will be the source of easily digestible practical information for pathologists faced with biopsies from this region. It will also guide gastroenterologists as they biopsy these patients.
    • The American Gastroenterological Association claims there are 14,500 members worldwide who are practicing physicians and scientists who research, diagnose and treat disorders of the gastrointestinal tract and liver
    • According to the American Society for Clinical Pathology, there are 12,000 board certified pathologists in the U.S.
    • Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world
    • Approximately 40% of the adult population of the U.S. suffers from significant heartburn and the numerous antacids advertised on national television represents an $8 billion per year drug market
    LanguageEnglish
    PublisherAcademic Press
    Release dateAug 29, 2011
    ISBN9780080878034
    Unavailable
    Diagnostic Atlas of Gastroesophageal Reflux Disease: A New Histology-based Method
    Author

    Parakrama T. Chandrasoma

    Dr. Parakrama Chandrasoma was born in Sri Lanka and received his medical education and initial pathology training in the Medical School of the University of Sri Lanka. He has postgraduate degrees in internal medicine, including the M.D. (Sri Lanka) and Membership of the Royal College of Physicians (UK). He immigrated to the United States in 1978. Upon completing his pathology residency, he assumed duties as Chief of Surgical Pathology at the Los Angeles County + University of Southern California Medical Center He has held this position since. After an initial interest in neuropathology, Dr. Chandrasoma joined Dr. Tom DeMeester’s Foregut Surgery team as pathologist in 1991. This led to a productive study of gastroesophageal reflux disease spanning 16 years and resulting in the development of numerous original concepts relating to the pathogenesis of gastroesophageal reflux disease. Dr. Chandrasoma has written over 140 peer reviewed papers and 6 previous pathology textbooks, including a general text on Gastrointestinal Pathology and a text on Gastroesophageal Reflux Disease, and is a Professor of Pathology at the Keck School of Medicine at the University of Southern California. He is married with three children and lives in Pasadena, California.

    Read more from Parakrama T. Chandrasoma

    Related to Diagnostic Atlas of Gastroesophageal Reflux Disease

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      A Welcome Side Effect: Novartis Anti-Inflammatory May Cut Risk of Lung Cancer, Study Finds

      Aug 27, 2017

      A Novartis anti-inflammatory drug sharply reduced lung cancer rates in a global study that also found it cut cardiovascular risk for heart attack survivors.

      3 min read

    • Article

      Conquer Your Heartburn

      Dec 12, 2023

      Conquer Your Heartburn
      6 min read

    • Article

      The Metabolic Approach

      Nov 21, 2021

      Almost 100 years ago, the German physician, researcher and Nobel Laureate Otto Warburg proposed that the primary cause of cancer is a metabolic dysfunction of the mitochondria. Mitochondria are the cellular powerplants that produce ATP, the energy so

      2 min read

    • Article

      Driving A Better Future For Patients

      Jul 30, 2020

      It’s oft-quoted among the medical fraternity, “it is quite as important for the doctor to know what kind of patient the disease has for host, as to know what sort of disease the patient has for guest”. A century and a quarter later, the statement sta

      1 min read

    • Article

      In Sickness And In Health

      Aug 4, 2022

      Health, wellbeing and illnesses are topics that encompass numerous aspects to write about, including medical conditions and their treatments, healthy living, personal accounts of coping with an illness, history of healthcare and ethical issues. There

      3 min read

    • Article

      Hispanic Patients On Ventilators Are More Likely To Be Heavily Sedated

      Feb 15, 2024

      Hispanic patients who are hospitalized with respiratory failure are five times more likely than non-Hispanic patients to receive deep sedation while on a ventilator, according to a new study. The study is the first to identify what may be driving wor

      2 min read

    • Article

      Biomarkers Identify Sight-stealing, Flesh-eating Infection

      Jul 9, 2018

      Scientists have discovered several biomarkers that can accurately identify what could be the next superbug—hypervirulent Klebsiella pneumoniae. The pathogen infects completely healthy people and can cause blindness in one day and flesh-eating infecti

      3 min read

    • Article

      Blood Test For Cancer Uses Sticky Malaria Protein

      Aug 16, 2018

      Researchers have come up with a new method of diagnosing cancer in its early stages in humans by way of a malaria protein—VAR2CSA—that sticks to cancer cells. All the scientists need to determine whether or not a person has cancer is a blood sample.

      3 min read

    • Article

      The Cancer Custodians

      Jun 23, 2021

      Part of Dennis Plenker’s daily job is growing cancer. And a variety of different ones, too. Depending on the day and the project, different tumors may burgeon in the petri dishes stocked in the Cold Spring Harbor Laboratory where Plenker works as a r

      11 min read

    Related categories

    Reviews for Diagnostic Atlas of Gastroesophageal Reflux Disease

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words